Clinical Trial Update: Oral Cladribine in Early Multiple Sclerosis (MS) [Phase 3]

View source ↗

Summary

Phase 3 trial update for oral cladribine in early multiple sclerosis has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cladribine (cladribine)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2013-10-10